InSights Hub

Miscellaneous

Showing 61 to 70 of 360 (Page 7)

Guidelines Spotlight Gastropancreatic Neuroendocrine Tumors

Gastroenteropancreatic Neuroendocrine Tumors – Guidelines Spotlight

In this edition of our Guideline Spotlight, we will explore the key insights and takeaways from the American Society of Clinical Oncology’s (ASCO) comprehensive guideline, Systemic Therapy for Tumor Control in Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This guideline offers evidence-based recommendations for the treatment of advanced or metastatic GEP-NETs, a rare group of tumors […]

Read More
Guidelines Rundown - Epilepsy

Epilepsy – Guidelines Rundown (Epilepsy Awareness Month)

November is National Epilepsy Awareness Month (NEAM), a time dedicated to raising awareness about epilepsy and supporting research efforts. In honor of NEAM, our Guidelines Rundown Series presents a new article focusing on epilepsy. Epilepsy is a well-known condition that affects 1% of adults in the United States. According to the Centers for Disease Control […]

Read More

Fluticasone Furoate, Umeclidinium, & Vilanterol Inhalation Powder (Trelegy Ellipta/GSK) – Guidelines+ Monographs

Welcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication fluticasone furoate, umeclidinium, and vilanterol, marketed under the brand name Trelegy Ellipta by GlaxoSmithKline. Trelegy Ellipta is a combination of fluticasone furoate, an inhaled corticosteroid (ICS); umeclidinium, an anticholinergic; and vilanterol, a long-acting beta2-adrenergic agonist (LABA) indicated […]

Read More
Guidelines Rundown - Premature Birth

Premature Birth – Guidelines Rundown (National Prematurity Awareness Month)

November is recognized as National Prematurity Awareness Month, with World Prematurity Day being observed annually on November 17th to raise awareness about preterm birth. The incidence of preterm birth is increasing globally, with an estimated 15 million infants born preterm each year (more than 3 weeks early), as reported by the World Health Organization (WHO). […]

Read More

SCAI’s Guideline for the Management of Chronic Venous Disease is Now Open for Public Comment

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced that the latest draft of the Clinical Practice Guidelines for the Management of Chronic Venous Disease is now available for public comment.  Chronic Venous Disease (CVD) is a condition that is often overlooked by healthcare providers, yet it can have a significant impact on patients’ […]

Read More
What's Changed Dravet Syndrome

Dravet Syndrome Guidelines – What’s Changed

Dravet syndrome is a rare form of epilepsy that typically manifests in infancy or early childhood. According to the National Institutes of Health (NIH), initial symptoms often present as either focal or generalized convulsive seizures that begin before the age of 15 months, with many cases occurring before the age of one. These initial seizures […]

Read More
Canadian Coalition for Seniors’ Mental Health (CCSMH) Int'l Guidelines

Canadian Coalition for Seniors’ Mental Health (CCSMH) – Guidelines International Series

In this installment of our Guidelines International Series, we will delve into the guidelines established by the Canadian Coalition for Seniors’ Mental Health (CCSMH). The CCSMH is committed to enhancing the quality of care and support for older adults throughout Canada. Their primary focus is on bridging gaps in knowledge and practice to ensure that […]

Read More
Guidelines Spotlight Non-Muscle Invasive Bladder Cancer

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer – Guidelines Spotlight (Bladder Health Awareness Month)

In the United States, it is estimated that there will be 83,190 new cases of bladder cancer and 16,840 bladder cancer-related deaths in 2024. Approximately 25% of newly diagnosed patients are found to have muscle-invasive disease, a statistic that has remained relatively unchanged over the past decade according to data from the Surveillance, Epidemiology, and […]

Read More
What's Changed Prurigo Nodularis

Prurigo Nodularis – What’s Changed

Prurigo nodularis is a chronic skin condition that impacts an estimated 75,000 individuals in the United States (US). This condition is characterized by persistent and intense itching, significantly impacting the quality of life for those affected. Research has shown a higher prevalence of prurigo nodularis among individuals with certain comorbidities, such as mental health, endocrine, […]

Read More
Guidelines Side-By-Side Chronic Constipation

Comparing Chronic Constipation Guidelines – Guidelines Side-By-Side

Constipation is a prevalent gastrointestinal disorder, affecting approximately 15% of the global population. It is more commonly diagnosed in North America and Europe compared to Asia, likely due to variations in diet, culture, and environment. Risk factors for constipation include age over 65, female gender, sedentary lifestyle, low socioeconomic status, low-fiber diet, and non-White race. […]

Read More
« Back to InSights Hub